Jennifer A Ligibel Selected Research

Glucose (Dextrose)

3/2015	Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
2/2008	Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer A Ligibel Research Topics

Disease

43	Breast Neoplasms (Breast Cancer) 05/2022 - 06/2002
28	Neoplasms (Cancer) 04/2022 - 08/2010
9	Fatigue 01/2022 - 06/2014
7	Weight Loss (Weight Reduction) 03/2022 - 07/2014
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2022 - 09/2014
6	Obesity 01/2021 - 12/2012
5	Pain (Aches) 01/2022 - 07/2014
5	Body Weight (Weight, Body) 01/2018 - 02/2008
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2011
3	Overweight 01/2021 - 02/2008
2	Second Primary Neoplasms (Neoplasms, Second) 03/2022 - 11/2014
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Leukemia 01/2021 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 05/2013
2	Insulin Resistance 02/2020 - 02/2008
2	Weight Gain 01/2019 - 08/2010
2	Lymphedema (Milroy Disease) 09/2014 - 04/2013
2	Brain Neoplasms (Brain Tumor) 11/2013 - 12/2011
1	Nausea 05/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Menstruation Disturbances 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Diarrhea 01/2022
1	Postoperative Pain 01/2022
1	Hypesthesia (Numbness) 09/2021
1	Sarcopenia 09/2020
1	Heart Diseases (Heart Disease) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Anemia 07/2017
1	Triple Negative Breast Neoplasms 07/2015

Drug/Important Bio-Agent (IBA)

11	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 07/2009
10	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2013
8	Hormones (Hormone)IBA 01/2022 - 04/2003
5	Insulin (Novolin)FDA Link 10/2021 - 02/2008
5	Aromatase InhibitorsIBA 09/2018 - 04/2003
3	taxaneIBA 01/2021 - 07/2015
3	LeptinIBA 02/2020 - 10/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2015 - 06/2002
2	Lapatinib (GW572016)FDA Link 01/2022 - 11/2013
2	Biological ProductsIBA 12/2020 - 09/2019
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2018
2	C-Reactive ProteinIBA 12/2020 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 06/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 02/2008
2	Tamoxifen FDA LinkGeneric 01/2012 - 04/2003
1	BiguanidesIBA 01/2022
1	Mucin-1 (CA 15-3 Antigen)IBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	MucinsIBA 10/2021
1	AntigensIBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021
1	Proteasome InhibitorsIBA 09/2021
1	Taxoids (Taxanes)IBA 09/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020
1	Muscle Proteins (Muscle Protein)IBA 09/2020
1	Amino Acids FDA Link 09/2020
1	SolutionsIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 09/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 07/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2016
1	Vascular Endothelial Growth Factor BIBA 01/2016
1	Estrogen ReceptorsIBA 09/2015
1	Pharmaceutical PreparationsIBA 09/2015
1	Docetaxel (Taxotere)FDA Link 07/2015

Therapy/Procedure

24	Therapeutics 01/2022 - 01/2003
17	Drug Therapy (Chemotherapy) 05/2022 - 06/2002
6	Adjuvant Chemotherapy 10/2021 - 08/2010
4	Caloric Restriction 03/2022 - 01/2017
3	Aftercare (After-Treatment) 04/2022 - 06/2014
3	Preoperative Exercise 03/2022 - 09/2019
3	Length of Stay 01/2022 - 05/2013
3	Resistance Training 11/2019 - 02/2008
3	Radiotherapy 07/2014 - 12/2011
1	Ear Acupuncture 05/2022
1	Music Therapy 04/2022
1	Massage (Zone Therapy) 01/2022
1	Integrative Oncology 01/2022
1	Qigong (Qi Gong) 01/2022
1	Meditation 01/2022
1	Acupuncture Therapy 01/2020
1	Cardiac Rehabilitation 01/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 10/2018
1	Continuity of Patient Care 01/2018
1	Segmental Mastectomy (Lumpectomy) 11/2016
1	Terminal Care (Care, Terminal) 08/2015